Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future
> Market
Uteron Pharma : Research for woman future

2013/01/23 : Watson Acquires Uteron Pharma

Read more


2012/05/2 : Uteron Pharma is contemplating a public offering to finance the (...)

Read more


2012/04/24 : Professor Jean-Michel Foidart has been awarded the Bologne-Lemaire (...)

Read more



Uteron Pharma : Research for woman future

Market

The worldwide contraceptive market (temporary methods of birth control) can be estimated at €7.5 billion divided over various methods. There is a wide variety of contraceptive methods available and contraceptive usage, both in terms of prevalence and methods, which varies considerably from one country and region to another, in function of economic, social, cultural and medical factors. In the charts and tables hereafter, an overview of prevalence and methods used in the different parts of the world is presented.

Contraceptive prevalence

    World More developed regions Less developed
regions
Number of Women aged 15-49 married or in union, 2007 (Thousand)   1.134.650 154.469 980.181
Prevalence of modern methods
Sterelization (female)
Sterelization (male)
Pill
Injectable or implant
Intra-uterine device
Condom
Vaginal barrier method
Other modern methods
19.7 %
2.7 %
8.5 %
3.4 %
15.5 %
5.7 %
0.3 %
0.2 %
8.6 %
4.5 %
16.5 %
1.0 %
9.4 %
13.9 %
1.9 %
0.3 %
21.5 %
2.5 %
7.2 %
3.7 %
16.5 %
4.4 %
0.1 %
0.1 %
Prevalence of traditional methods
Rhythm
With-drawal
Other traditional methods
3.6 %
2.9 %
0.5 %
4.3 %
6.8 %
0.2 %
3.4 %
2.3 %
0.6 %
Any method   63.1 % 67.4 % 62.4 %
 

Graphs

PNGPNGPNG

 




© 2011 Uteron Pharma - Legal - Privacy policy Designed and Powered by Lusis Communication

Company

Background
History
Location
Contact us

Products

Levosert™
Diafert™

Production

Market

Newsroom

Uteron Pharma : Research for woman future